Myositis Ossificans (MO) is a condition that occurs following a direct traumatic injury that results in a contusion, or bruise. Such injuries are common in contact sports like rugby or football, where an athlete takes a direct hit from an opponent. However, anyone can sustain a serious contusion from a fall, or from running into an obstacle.
Not all contusions lead to MO, and the condition is more likely to arise from a contusion to the large muscles of the thigh or upper arm. In some instances, MO arises as a result of repetitive minor trauma. For example, it sometimes occurs on the inner thighs of equestrians. While it is more common in the tissue of large muscles, MO sometimes occurs in fat, tendons, ligaments, and fascia.
Initially, an injury leading to MO presents as a painful bruise, where a pool of blood forms a hematoma, or blood clot, over the injury. Unlike a normal contusion, pain and inflammation are not responsive to traditional soft tissue treatments like NSAIDs, icing, and immobilization of the muscle. MO is most commonly seen in teens and young adults, although older adults can develop MO after an injury or surgery. The condition is rare in children.
MO arises when the site of injury forms a benign lesion containing active fibroblasts and osteoblasts that begin to form bone within the soft tissue. Early damage is followed by the swelling of soft tissues that grows over the course of several weeks into a painful solid mass. MO is often not discovered until several weeks after the initial injury occurs, when pain, loss of function and reduced range of motion persist.
What causes myositis ossificans is poorly understood. Many believe it is due to a malfunction in repair mechanisms that cause abnormal fibroblasts to become osteogenic cells.
When your injury does not begin to heal after one to two weeks of traditional soft tissue treatment of NSAIDs, rest, ice, and elevation, you should consider the possibility of MO. During the clinical exam, your health care provider will ask for details about when and how you became injured, and what treatment measures were taken, and they will examine and palpate the injured area.
If your provider suspects MO, they will confirm it with imaging, such as X-ray, MRI, or diagnostic ultrasound. Real time diagnostic ultrasound such as that used at NYDNR can provide real time images in motion while you provide feedback, to help your clinician make an accurate diagnosis and assess the severity of your injury.
Aplio i800 ultrasound
STORZ MEDICAL shockwave
In the early aftermath of injury, traditional treatment focuses on controlling pain and inflammation with NSAIDs, elevation, rest, and immobilization of the damaged area.
If pain persists and function and range of motion continue to deteriorate after four to six months, surgery is often considered to remove the mass. However, if surgery is performed prematurely, calcium deposits may remain and continue to grow. Moreover, surgical removal of the mass can result in permanent damage to the muscle, preventing it from regaining full strength and function.
Recently, a new treatment approach, ESWT (extracorporeal shockwave therapy), is showing overwhelming success in treating MO.
A study conducted by Buselli et al. (2010) of 24 young male athletes who incurred MO subsequent to traumatic contusion found that the condition was not responsive to traditional treatment methods that included icing, physical therapy and analgesics, and that as the condition persisted, the subjects experienced increasing pain, reduced function and reduced range of motion in the affected area.
The subjects were then treated with three sessions of ESWT combined with physical therapy. Although researchers observed only a partial reduction of ossification, functional improvements and reduced pain were seen immediately after ESWT therapy. Two months after therapy, range of motion and muscle strength were completely restored, and three months after treatment, 87.5% of subjects returned to their pre-injury level of play.
At NYDNR, we treat MO with ESWT and physical therapy, with the aim of eliminating pain and restoring strength, range of motion and optimal function of the affected tissues. To date, we have experienced 100% effectiveness in eliminating pain in patients suffering from MO.